Durable Medical Equipment (DME) Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     Global Durable Medical 
Equipment (DME) Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
IMARC Group is  a g lobal  management  consul t ing f i rm that  he lps the wor ld ’s  most  ambi t ious 
changemakers  to create a las t ing impact .  Across the s ix  major  cont inents  and 100+ count r ies ,  we 
work a longside our  bus iness par tners  as one team wi th  a common ambi t ion to achieve unparal le led 
resul ts ,  gain a compet i t ive edge,  and t ransform indust r ies .  IMARC Group excels  in  unders tanding 
i ts  c l ients ’  bus iness pr ior i t ies  and del iver ing ta i lored solut ions that  dr ive meaningfu l  outcomes.  Our 
c l ient  base spans over  3,000 organizat ions in  the pr ivate,  publ ic ,  and soc ia l  sectors ,  ranging f rom 
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of  market  entry  and expansion serv ices.  Our of fer ings inc lude 
thorough market  assessment ,  feas ib i l i ty  s tudies,  company incorporat ion ass is tance,  fac tory  setup 
suppor t ,  regulatory  approvals and l icens ing navigat ion,  branding,  market ing and sales st rategies,  
compet i t ive landscape and benchmark ing analyses,  pr ic ing and cost  research,  and procurement  
research.  These serv ices are des igned to ass is t  companies in  evaluat ing market  oppor tuni t ies ,  
set t ing up new ent i t ies ,  navigat ing regulatory landscapes,  boost ing brand v is ib i l i ty ,  analyz ing 
compet i tors,  and opt imiz ing procurement  s t rategies.
Acco r d ing  t o  t he  l a t es t  r epo r t  by  I M ARC  G r ou p ,  t i t l e d  " Dura b l e  M ed i c a l  Equ i pm ent  
( DM E)  M ark e t :  G l o ba l  I ndus t ry  T rend s ,  S hare ,  S i z e ,  G row t h ,  O pp or t un i t y  and  
For ec as t  2024 - 2032 , "  t he  g loba l  du r a b le  m e d ica l  eq u ipm en t  ( D M E)  m ar ke t  s i ze  
r eac hed  US$  2 17 . 0  B i l l i on  i n  20 23 .
Dur ab le  m ed ica l  equ ip m en t  i s  us ed  i n  c l i n i cs ,  h osp i t a l s ,  and  hom e  ca r e  se t t i ng s  t o  
Report p r ov ide  a  be t t e r  q ua l i t y  o f  l i f e  t o  pa t i en t s  w i t h  deb i l i t a t i ng  m e d ica l  co nd i t i on s ,  
i l l nes ses ,  o r  i n j u r ie s .  I t  i s  cov e r ed  i n  m a ny  i nsu r ance  po l i c i e s  and  i nc lude s  i r on  
Highlight and l ungs ,  c a t he t e r s ,  CP AP,  hos p i t a l  beds ,  i r on  l un gs ,  ne bu l i ze r s ,  oxyge n  t e n t s ,  b loo d -t es t i ng  s t r i ps  and  b lood  g luco se  m on i t o r s ,  a nd  w hee lch a i r s .  
I t  i s  f u r n i she d  on  a  r en t a l  bas i s  f o r  a  l ong  du r a t i o n  o r  pu r chase d .  I t  i s  p r esc r ib ed  by  
Description a  ph ys i c ian  o r  hea l t hca r e  p r o v ide r  t o  accom m o da t e  a  p a t i en t ' s  t em p or a r y  d i sab i l i t y ,  
as  i n  t h e  c ase  o f  a  whee lc ha i r  o r  c r u t ch es  f o r  a  r ecove r ing  pa t i en t ,  o r  as  p a r t  o f  a  
pa t i en t ' s  l ong - t e r m  ca r e  p lan  f o r  t he i r  ch r on i c  o r  l i f e - l im i t i ng  c ond i t i o n ,  suc h  as  a  
m ec han ic a l  ven t i l a t o r  f o r  a  p a t i en t  w i t h  adv anced  l ung  d i se ase .
Reque st  f o r  a  PDF  sam pl e  o f  t h i s  re por t :  
h t t p s : / / www. im ar c g r ou p . com / du r ab le - m ed ic a l - eq u ipm e n t - m ar ke t / r e ques t sam p le
Report Description
Gl o b a l  D u r ab l e  Me d i c a l  E q u ip m e n t  ( D M E )  M ar k e t  T r e n d s :
T he  g l o b a l  m a r k e t  i s  m a j o r l y  d r i v e n  b y  t he  i nc r e a s i n g  i n c i d e n ce s  o f  c a n c e r ,  c a r d i a c  d i so r d e rs ,  ne u r o l og i c a l  c o nd i t i o n s ,  a n d  
gy n e c o l og i c a l  c o mp l i c a t i on s .  I n  l i n e  w i t h  t h i s ,  b e t te r  c o v e r a g e  a n d  f av o r a b l e  r e i mb u r s e me n t  p o l i c i e s  fo r  d u r ab l e  me d i c a l  
eq u i p me n t  p r o d uc t s  a r e  e x pe c t e d  t o  p os i t i v e l y  i n f l u en c e  t h e  p r o d u c t  de m a n d .  F u r t he r mo r e ,  t h e  r i s i n g  nu m b e r  o f  e l d e r l y  c a r e  
ce n t e r s  d u e  to  t he  e x p an d i n g  ge r i a t r i c  p o p u l a t i o n  b as e  a nd  i t s  s u s c e p t i b i l i t y  t o  s k e l e t a l ,  c a rd i a c ,  a n d  n e u r o l o g i c a l  c o n d i t i o n s ,  
w h i c h  a ug m e n ts  t h e  n e e d  f o r  l o ng - t e rm  c a re  a n d  r e c o v e r y ,  a r e  a n t i c i p a t ed  t o  i nc r e a se  t h e  d e m a nd  f o r  D M E  p r o d uc t s .  
Mo r e ov e r ,  t he  i n t r o du c t i o n  o f  t e c hn o l o g i c a l l y  a d v a nc e d  p r o d u c t s  w i t h  i m p ro v e d  p a t i e n t  c o mf o r t  a n d  po r t a b i l i t y  i s  c r e a t i n g  a  
po s i t i v e  o u t l o o k  f o r  t h e  m a r ke t .  A d d i t i o n a l l y ,  t h e  e sc a l a t i ng  p r e f e r e n c e  fo r  a v a i l i ng  p os t - o pe r a t i v e  a n d  l o n g - t e r m  ca r e  a t  ho m e  
i s  p r o v i d i n g  a  bo o s t  t o  t h e  m a rk e t .  S o me  o f  t h e  o t h e r  f ac t o r s  d r i v i ng  t he  ma r k e t  e x p an s i o n  i nc l u d e  c o n t i n u a l  t e c h n o l o g i c a l  
ad v a n ce m e n ts  i n  D ME ,  i n f l a t i n g  d i s p o s ab l e  i n c om e s  o f  c o ns u m er s ,  a nd  r a p i d  a d o p t i on  o f  h o m e- b a s e d  m o n i to r i n g  d e v i c e s .
L o o k i n g  f o rw a r d ,  t h e  m ar k e t  i s  an t i c ip a t e d  t o  r e a c h  a  v a l u e  o f  U S $  3 5 6 . 2  B i l l io n  b y  2 03 2 ,  ex h i b i t i n g  a  C A G R  o f  5 .5 %  
d u r i n g  2 0 2 4 -2 0 3 2 .
V i e w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w ww . i m a r c g ro u p . co m / d u ra b l e - m e d i ca l - e q u i p m en t - m ar k e t
Breakup by Product:
• Personal  Mobi l i ty  Devices
o Wheelchairs
o Scooters
o Walker and Rol lators
o Cranes and Crutches
o Door Openers
o Others
Report • Bathroom Safety Devices and Medical  Furniture
Segmentation o Commodes and Toi lets
o Mattress and Bedding Devices
• Monitor ing and Therapeutic  Devices
o Blood Sugar Monitors
o Cont inuous Pass ive Mot ion (CPM)
o In fus ion Pumps
o Nebul izers 
o Oxygen Equipment
o Cont inuous Posit ive Airway Pressure 
(CPAP)
o Suct ion  Pumps
o Tract ion  Equ ipment
o Others  
Breakup by End Use:
• Hosp i ta l
• Nurs ing  Homes
Report • Home Heal thcare
• Others
Segmentation
Breakup by Region:
• North  Amer ica
• Asia-Pac ifi c
• Europe
• Lat in  Amer ica
• Midd le East  and Afr ica
• ArjoHunt leigh
• Becton
• Dickinson and Company
• General  E lectr ic  Company
Competitive • GF Health Products Inc.
• Hil l -Rom Services Inc. ,
Landscape • Invacare Corporat ion
with Key • Koninkl i jke Phi l ips NV
• Medical  Device Depot  Inc.
Players
• Medl ine Industr ies Inc.
• Medtronic PLC
• Omron Corporat ion
• Siemens Healthineers AG (Siemens AG)
• Stryker  Corporat ion.
What was the size of the global Durable Medical 
Equipment (DME) market in 2023?
What is the expected growth rate of the global Durable 
Medical Equipment (DME) market during 2024-2032?
What are the key factors driving the global Durable 
Key Medical Equipment (DME) market?
Questions What has been the impact of COVID-19 on the global 
Durable Medical Equipment (DME) market?
Answered in 
What is the breakup of the global Durable Medical 
the Report Equipment (DME) market based on the product?
What is the breakup of the global Durable Medical 
Equipment (DME) market based on the end use?
What are the key regions in the global Durable Medical 
Equipment (DME) market?
Who are the key players/companies in the global 
Durable Medical Equipment (DME) market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  D u r a b l e  M e d i c a l  E q u i p m e n t  ( D M E )  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t
    6 . 1     P e r s o n a l  M o b i l i t y  D e v i c e s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  K e y  S e g m e n t s
           6 . 1 . 2 . 1  W h e e l c h a i r s
           6 . 1 . 2 . 2  S c o o t e r s
           6 . 1 . 2 . 3  W a l k e r  a n d  R o l l a t o r s
           6 . 1 . 2 . 4  C r a n e s  a n d  C r u t c h e s
           6 . 1 . 2 . 5  D o o r  O p e n e r s
           6 . 1 . 2 . 6  O t h e r s
        6 . 1 . 3  M a r k e t  F o r e c a s t
       
    6 . 2     B a t h r o o m  S a f e t y  D e v i c e s  a n d  M e d i c a l  F u r n i t u r e
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  K e y  S e g m e n t s
           6 . 2 . 2 . 1  C o m m o d e s  a n d  T o i l e t s
           6 . 2 . 2 . 2  M a t t r e s s  a n d  B e d d i n g  D e v i c e s
        6 . 2 . 3  M a r k e t  F o r e c a s t
    6 . 3     M o n i t o r i n g  a n d  T h e r a p e u t i c  D e v i c e s
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  K e y  S e g m e n t s
           6 . 3 . 2 . 1  B l o o d  S u g a r  M o n i t o r s
           6 . 3 . 2 . 2  C o n t i n u o u s  P a s s i v e  M o t i o n  ( C P M )
Table of            6 . 3 . 2 . 3  I n f u s i o n  P u m p s
           6 . 3 . 2 . 4  N e b u l i z e r s
           6 . 3 . 2 . 5  O x y g e n  E q u i p m e n t
Contents            6 . 3 . 2 . 6  C o n t i n u o u s  P o s i t i v e  A i r w a y  P r e s s u r e  ( C P A P )           6 . 3 . 2 . 7  S u c t i o n  P u m p s
           6 . 3 . 2 . 8  T r a c t i o n  E q u i p m e n t
           6 . 3 . 2 . 9  O t h e r s
        6 . 3 . 3  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  E n d  U s e
    7 . 1     H o s p i t a l
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     N u r s i n g  H o m e s
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     H o m e  H e a l t h c a r e
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / d u r a b le - m ed i c a l - eq u ip m e n t - m a r ke t
/ t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: